Physician

John Mark Redwine, MD

According to 2025 Medicare claims, John Redwine, MD (NPI: 1548227101) practices family practice in the Charleston-North Charleston, SC market, with the plurality of this provider's patient population coming from Berkeley, SC. This provider's primary affiliated billing organization is PALMETTO PRIMARY CARE PHYSICIANS, LLC (NPI: 1659660645; TIN: 57-1056849) and primary practice location at 29406-9844. Redwine is affiliated with the Avant MSO (ACO ID: A3094), participating under the MSSP model.

Redwine's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 4,005 traditional Medicare patients, billed 21,669 HCPCS/CPT codes, and received $461,707 in Medicare payments. The top billing code was 84443 (Blood test, thyroid stimulating hormone (tsh)). Part D data shows 11,318 prescription claims across 931 beneficiaries totaling $1,215,629 in drug costs, led by Ozempic (Semaglutide). DME data shows 99 claims. Open Payments data shows 43 records totaling $920. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $204,847 to $461,707. Similarly, Part D prescription costs have risen steadily, from $394,661 to $1,215,629. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,973 and ending at $29,429.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	913	4,351	$204,847
2016	983	4,521	$199,482
2017	1,026	6,585	$262,285
2018	981	6,377	$246,460
2019	985	6,170	$257,385
2020	913	5,514	$228,591
2021	949	5,920	$278,196
2022	913	5,246	$269,019
2023	833	4,711	$230,535
2024	4,005	21,669	$461,707

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	634	6,172	$394,661
2016	703	7,260	$540,301
2017	711	8,305	$632,832
2018	743	8,914	$660,873
2019	781	9,398	$670,362
2020	793	10,310	$805,384
2021	844	10,799	$852,129
2022	868	10,307	$839,373
2023	860	10,048	$991,541
2024	931	11,318	$1,215,629

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	98	197	$2,710
2016	98	205	$2,282
2017	55	152	$1,552
2018	62	148	$1,626
2019	50	214	$4,444
2020	42	166	$3,707
2021	43	156	$6,311
2022	38	125	$5,804
2023	20	93	$5,240
2024	28	99	$5,733

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
84443	Blood test, thyroid stimulating hormone (tsh)	1,355	1,363	$16
80061	Blood test, lipids (cholesterol and triglycerides)	2,231	2,239	$13
80053	Blood test, comprehensive group of blood chemicals	2,487	2,505	$10
83036	Hemoglobin a1c level	1,922	1,933	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	2,126	2,139	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	160	8,342	$265,028
Eliquis	Apixaban	89	5,842	$109,842
Mounjaro	Tirzepatide	62	2,980	$109,328
Trulicity	Dulaglutide	59	3,396	$108,781
Jardiance	Empagliflozin	60	4,478	$79,377

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	13	$3,077
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$1,792
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	16	36	$432
B4155	Enteral formula, nutritionally incomplete/modular nutrients, includes specific nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g., glutamine, arginine), fat (e.g., medium chain triglycerides) or combination, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$399
A4259	Lancets, per box of 100	N	12	28	$33

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$920	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Mark Redwine, MD?

Tedicare shows public-source Medicare data for John Mark Redwine, MD (NPI 1548227101), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Mark Redwine, MD have ACO affiliation data?

John Mark Redwine, MD is shown with ACO affiliation data for Avant MSO (MSSP, ACO ID A3094).

What billing organization is linked to John Mark Redwine, MD?

John Mark Redwine, MD is linked to PALMETTO PRIMARY CARE PHYSICIANS, LLC (billing NPI 1659660645) in the available physician profile data.

Does John Mark Redwine, MD have Open Payments data?

John Mark Redwine, MD has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.